Welcome Linglu Hong!
We are happy to introduce our latest team member Linglu Hong.Linglu, MSc in Bio and Nano Materials, has experience in working with research projects related to biological characterization with bone cement. Currently, she is a PhD student at Uppsala University specializing in Biomedical Engineering and will also be working as a Researcher at Inossia focusing on […]
Important milestone – First North American patient treated
July 31, 2023 Dr. Olivier Clerk-Lamalice and his team at Beam Radiology in Calgary, which is part of our multicenter clinical trial, have now treated their first patient. With this milestone, we now also have treated patients, in North America, not only in Europe. The purpose of the clinical trial is to show a statistically […]
Inossia receives higher company valuation and oversubscribes investment round
June 21, 2023 Press release: Inossia, a leading medical technology company in active aging and treatment of back pain, announces today that it has successfully completed its latest investment round. The round was oversubscribed and resulted in a capital injection of over SEK 10.5 million.Earlier this spring, Inossia has been selected as one of the […]
Important approval from Health Canada
May 2, 2023. We are very happy for the approval from Health Canada to add a Canadian clinic, Beam Radiology in Calgary, to our multicenter clinical trial.This will enable us to include North American patients in the ongoing study, which is an important step toward the North American market. We say a warm welcome to […]
Inossia awarded 7.3 million Euros in funding from the European Innovation Council (EIC) Accelerator Programme
March 29, 2023 Inossia is very happy and proud to be one of the selected projects awarded the sum of 7.3 million Euros from the European Innovation Council (EIC) Accelerator Programme. The awarded sum is divided in 2.3 million euros in grant and 5.0 million euros in equity. The EIC Accelerator award supports, in particular, […]
Welcome Akanksha Mishra!
We are happy to introduce our latest team member Akanksha Mishra.Akanksha has an extensive experience in quality and regulatory affairs from the medical device and pharmaceutical sector. Before joining Inossia, Akanksha was a regulatory affairs specialist at Brighter. Warm welcome Akanksha as a valuable member of our team!
Additional Spanish hospital joining our clinical trial
November 8, 2022. Inossia has a steady enrolment pace in our multicenter clinical trial. We are now very pleased to add an additional Spanish hospital. Looking forward to valuable contributions from Dr. David Noriega, who is an important key opinion leader, and the rest of the team at Hospital de Medina del Campo in Valladolid, […]
EIT Health -Softbone project- meets in Madrid
November 2-3, 2022 – Inossia was in Madrid and had a meeting with the participants from the EIT Health project SOFTBONE. This is our European multicenter randomized clinical trial. The aim is to show a reduced amount of new and unnecessary spinal fractures when using our soft bone cement V-Flex compared to conventional bone cement. Learn more […]
Inossia adds a new country Poland to our medical trial
October 25, 2022. Inossia adds a new country, Poland, to our medical clinical trial of soft cement V-Flex. Medical University of Lodz will be a valuable contribution to the growing trial that is ongoing in Germany and Spain. We are happy to welcome Dr. Maciej Radek, Dr. Jakub Janowski and the rest of the team […]
Inossia at Eurospine 2022
October 19-21, 2022 – Inossia was in Milan, at the congress of EUROSPINE, the Spine Society of Europe, internationally recognized as the leading event in the world of spine. Together with our partner company G21 and other professionals, we had interesting discussions related to spine care treatments. V-Flex, a flexible bone cement for percutaneous vertebral augmentation […]
